Mechanism of SGLT2 Inhibition in the Kidney
NCT06291155
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Diabetic Kidney Disease
Interventions
DRUG:
SGLT2 inhibitor
Sponsor
University of Michigan
Collaborators
[object Object]
[object Object]